Philippe Laffont, founder and chief investment officer of Coatue Management.
(Chris Goodney/Bloomberg)
The IPO market may be all but closed, except for a few biopharmaceutical companies. And many start-ups are seeking relief from the government’s bailout funds.But mostly, venture capital investing has not yet shown signs of devastation from the Covid-19.According to the PitchBook-NVCA Venture Monitor report,
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.